View in EDS HTML Full Text PDF Full Text

Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial.

Saved in:
Bibliographic Details
Title: Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial.
Authors: Khanna S; Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Yoho D; Mid-Atlantic Permanente Medical Group, Springfield, VA, USA., Van Handel D; MNGI Digestive Health, Minneapolis, MN, USA., Clark BJ; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Awad T; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Guthmueller B; Ferring Pharmaceuticals, Inc., Parsippany, NJ, USA., Armandi D; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Knapple W; Arkansas Gastroenterology, North Little Rock, AR, USA., Safdar N; University of Wisconsin, Madison, WI, USA., Baggott B; Cleveland Clinic, Cleveland, OH, USA., Simon K; Om Research, Camarillo, CA, USA., Feuerstadt P; PACT Gastroenterology Center, Yale School of Medicine, Hamden, CT, USA.
Source: Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2025 Apr 22; Vol. 18, pp. 17562848251339697. Date of Electronic Publication: 2025 Apr 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Sage Publications Country of Publication: England NLM ID: 101478893 Publication Model: eCollection Cited Medium: Print ISSN: 1756-283X (Print) Linking ISSN: 1756283X NLM ISO Abbreviation: Therap Adv Gastroenterol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40321366
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA<superscript>®</superscript>) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Khanna+S%22">Khanna S</searchLink>; Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.<br /><searchLink fieldCode="AU" term="%22Yoho+D%22">Yoho D</searchLink>; Mid-Atlantic Permanente Medical Group, Springfield, VA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Handel+D%22">Van Handel D</searchLink>; MNGI Digestive Health, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Clark+BJ%22">Clark BJ</searchLink>; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Awad+T%22">Awad T</searchLink>; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Guthmueller+B%22">Guthmueller B</searchLink>; Ferring Pharmaceuticals, Inc., Parsippany, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Armandi+D%22">Armandi D</searchLink>; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Knapple+W%22">Knapple W</searchLink>; Arkansas Gastroenterology, North Little Rock, AR, USA.<br /><searchLink fieldCode="AU" term="%22Safdar+N%22">Safdar N</searchLink>; University of Wisconsin, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Baggott+B%22">Baggott B</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Simon+K%22">Simon K</searchLink>; Om Research, Camarillo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Feuerstadt+P%22">Feuerstadt P</searchLink>; PACT Gastroenterology Center, Yale School of Medicine, Hamden, CT, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101478893%22">Therapeutic advances in gastroenterology</searchLink> [Therap Adv Gastroenterol] 2025 Apr 22; Vol. 18, pp. 17562848251339697. <i>Date of Electronic Publication: </i>2025 Apr 22 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101478893 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1756-283X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221756283X%22">1756283X </searchLink><i>NLM ISO Abbreviation: </i>Therap Adv Gastroenterol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40321366
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17562848251339697
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17562848251339697
    Titles:
      – TitleFull: Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Khanna S
      – PersonEntity:
          Name:
            NameFull: Yoho D
      – PersonEntity:
          Name:
            NameFull: Van Handel D
      – PersonEntity:
          Name:
            NameFull: Clark BJ
      – PersonEntity:
          Name:
            NameFull: Awad T
      – PersonEntity:
          Name:
            NameFull: Guthmueller B
      – PersonEntity:
          Name:
            NameFull: Armandi D
      – PersonEntity:
          Name:
            NameFull: Knapple W
      – PersonEntity:
          Name:
            NameFull: Safdar N
      – PersonEntity:
          Name:
            NameFull: Baggott B
      – PersonEntity:
          Name:
            NameFull: Simon K
      – PersonEntity:
          Name:
            NameFull: Feuerstadt P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 04
              Text: 2025 Apr 22
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1756-283X
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Therapeutic advances in gastroenterology
              Type: main
ResultId 1